Make a enquiry

About LEXIPHARMA

Welcome to Lexipharma.com, your premier destination for comprehensive pharmaceutical law resources. Our portal is meticulously crafted with input from legal luminaries and guidance from leading drug regulators across the country.

The portal features a book titled ‘Exhaustive Commentary on the Drugs and Cosmetics Act, 1940, along with Allied Rules’, written by Mr. Sushant Mahapatra, a distinguished advocate of the Hon'ble Supreme Court of India and the head of the Mace Corporate Associates.

The book includes references to nine hundred judgments, and the hybrid version provides access to all judgments, allowing readers to focus on their research. Additionally, the online portal features a legal and regulatory database with information on CDSCO, DPCO, e-gazettes, daily updates, and more.

Lexipharma operates a research center that is deeply involved in pharmaceutical and nutraceutical regulations. This includes laws related to drugs, the Drug Price Control Order (DPCO), magical remedies, essential commodities, packaging requirements, intermediary regulations, clinical trials, medical devices, and various other related areas.

LEXIPHARMA

Lexipharma Hybrid Book Portal

Lexi Pharma, a platform with comprehensive resource that highlights its unique integration of traditional books with a dynamic online portal. Subscribers will have access to in-depth analysis that are found in traditional commentaries and real-time updates of latest judgments on the Lexi Pharma portal. The Lexi Pharma portal promises to offer tools for cross-referencing, quick access to relevant case laws, amendments, notifications and expert commentary just with a few clicks.

Lexi Pharma portal is tailored specifically for the pharmaceutical industry covering wide range of regulatory compliances defined under the statutes, rules and regulations. Further subscribers to the portal could be benefited from quick access to updated regulations and relevant precedents while working on the pharmaceutical cases.

Lexi Pharma’s hybrid publication model seamlessly integrates traditional legal commentary alongside the digital platform, where each commentary section in the portal is directly linked to the Hon’ble Court copies of relevant judgments. Subscribers, by clicking on the hyperlinks can instantly access the Court Orders and Judgments further allowing them to have a deeper understanding of the related legal provisions. To further supplement the subscriber, each section of the legal commentary in the portal includes a “Related Provisions” bar. This feature will guide the subscribers to related provisions, rules, schedules and forms. This feature ensures that the subscribers have access to all the relevant provisions and a comprehensive understanding of the subject matter at their fingertips.

The Lexi Pharma portal is updated daily to incorporate the latest Notifications, Circulars issued by the Central Government, thereby ensuring that the subscribers always have access to the latest legal developments, enabling them to have a thorough and up-to-date understanding of the related provisions. While the accompanying book covers over 900 relevant judgments, the Lexi Pharma portal extends this resource with more than 1,000 judgments, with an additional 500 judgments slated for inclusion. This expansive database allows subscribers to explore a wider range of legal precedents. The portal also categorizes judgments state-wise, highlighting binding precedents from High Courts, providing users with a more precise and jurisdiction-specific understanding of legal rulings. Further this model of Lexi Pharma is designed to facilitate easy and systematic navigation through connected sections, rules, schedules, forms and appendices, where subscribers can experience a seamless research experience that interlinks the theoretical aspects with the practical and real-time data available on the portal.

Curious To Dive Deeper? Let's Explore Together For A Richer Understanding.

Subscription